In this week’s episode of The Spotlight Roundup, we spotlight Field Trip Health as they complete the largest financing raise ever for a psychedelic company in Canada; Red Light Holland completes the sale and import of psychedelic truffles into Canada; Mind Cure Health launches a product sales division; and we look at New York, which may be on the brink of a big psychedelic boom.
Similar Posts
The Spotlight Roundup-The First-Ever Female Founded Psychedelic Company
July 7, 2021- This week’s Psychedelic Business News top stories…
I Tried 5-MeO-DMT at a Psychedelic Retreat. This is MY Story
Have you ever considered taking 5-MeO-DMT, also known as Bufo…
Best Areas to Forage for Psychedelic Mushrooms in the United States
Join our Newsletter (scroll to the bottom of the page…
Why Are Psychedelic Stocks Falling? (MindMed, Atai, Cybin, FieldTrip, Compass Pathways)
What’s up psychedelic investors! We have been seeing a lot of red in the last few months. Companies like MindMed (MNMD: NASDAQ) (MMED:NEO), atai Life Sciences (atai: NASDAQ), Field Trip (FTRP: TSE) ( FTRP: NASDAQ), Cybin (CYBN: NYSE) and many more have experienced a decline in stock prices. So in this episode, we’ll be discussing the reasons behind this and whether we are ignoring some red flags.
Enjoy the episode!
Follow us on social media! 🙌
Instagram: @thepsychedelicinvestor
Facebook: @thepsychedelicinvestor
Want to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.com
Music from:
www.bensound.com
Video editing: @themyaholy
Check out our Benziga discounts
https://benzinga.grsm.io/jameshallifa…
https://benzinga.grsm.io/thepsychedel…
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#MindMed #FieldTrip #PsychedelicStocks
Psychedelic Spotlight Interview with Joshua White
In this episode of the Psychedelic Spotlight podcast, we speak…
Psychedelic Spotlight Interview with Anthony Tennyson
In this episode of the Psychedelic Spotlight podcast, we feature…